Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective

<i>Background and Objectives:</i> We aimed to evaluate the oncological and functional outcomes of organ-sparing surgery for testicular germ cell tumors, a procedure that seeks to strike a balance between effective cancer control and organ preservation, in the treatment of testicular tumo...

Full description

Bibliographic Details
Main Authors: Esther García Rojo, Gianluca Giannarini, Borja García Gómez, Javier Amalio Feltes Ochoa, Félix Guerrero Ramos, Manuel Alonso Isa, Ricardo Brime Menendez, David Manuel Saenz Calzada, Juan Justo Quintas, Agustín Fraile, Celeste Manfredi, Javier Romero Otero
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/7/1249
_version_ 1797588389750374400
author Esther García Rojo
Gianluca Giannarini
Borja García Gómez
Javier Amalio Feltes Ochoa
Félix Guerrero Ramos
Manuel Alonso Isa
Ricardo Brime Menendez
David Manuel Saenz Calzada
Juan Justo Quintas
Agustín Fraile
Celeste Manfredi
Javier Romero Otero
author_facet Esther García Rojo
Gianluca Giannarini
Borja García Gómez
Javier Amalio Feltes Ochoa
Félix Guerrero Ramos
Manuel Alonso Isa
Ricardo Brime Menendez
David Manuel Saenz Calzada
Juan Justo Quintas
Agustín Fraile
Celeste Manfredi
Javier Romero Otero
author_sort Esther García Rojo
collection DOAJ
description <i>Background and Objectives:</i> We aimed to evaluate the oncological and functional outcomes of organ-sparing surgery for testicular germ cell tumors, a procedure that seeks to strike a balance between effective cancer control and organ preservation, in the treatment of testicular tumors. We aimed to discuss the surgical technique and complications, and determine the appropriate candidate selection for this approach. <i>Material and Methods:</i> A comprehensive literature search was conducted to identify relevant studies on organ-sparing surgery for testicular tumors. Various databases, including PubMed, Embase, and Cochrane Library, were used. Studies reporting on surgical techniques, complications, and oncologic and functional outcomes were included for analysis. <i>Results:</i> Current evidence suggests that organ-sparing surgery for testicular germ cell tumors can be considered a safe and efficacious alternative to radical orchiectomy. The procedure is associated with adequate oncological control, as indicated by low recurrence rates and low complication rates. Endocrine testicular function can be preserved in around 80–90% of patients and paternity can be achieved in approximately half of the patients. Candidate selection for this surgery is typically based on the following criteria: pre-surgery normal levels of testosterone and luteinizing hormone, synchronous or metachronous bilateral tumors, tumor in a solitary testis, and tumor size less than 50% of the testis. <i>Conclusions:</i> Organ-sparing surgery for testicular germ cell tumors offers a promising approach that balances oncological control and preservation of testicular function. Further research, including large-scale prospective studies and long-term follow-ups, is warranted to validate the effectiveness and durability of organ-sparing surgery and to identify optimal patient selection criteria.
first_indexed 2024-03-11T00:51:17Z
format Article
id doaj.art-e4ce73c4af7645578cd22d3e8ef12f2a
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-11T00:51:17Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-e4ce73c4af7645578cd22d3e8ef12f2a2023-11-18T20:23:59ZengMDPI AGMedicina1010-660X1648-91442023-07-01597124910.3390/medicina59071249Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current PerspectiveEsther García Rojo0Gianluca Giannarini1Borja García Gómez2Javier Amalio Feltes Ochoa3Félix Guerrero Ramos4Manuel Alonso Isa5Ricardo Brime Menendez6David Manuel Saenz Calzada7Juan Justo Quintas8Agustín Fraile9Celeste Manfredi10Javier Romero Otero11Department of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, SpainUrology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, ItalyROC Clinic Direction, Martínez Campos 17, 28010 Madrid, SpainROC Clinic Direction, Martínez Campos 17, 28010 Madrid, SpainDepartment of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, SpainROC Clinic Direction, Martínez Campos 17, 28010 Madrid, SpainDepartment of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, SpainROC Clinic Direction, Martínez Campos 17, 28010 Madrid, SpainDepartment of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, SpainROC Clinic Direction, Martínez Campos 17, 28010 Madrid, SpainUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 81100 Naples, ItalyDepartment of Urology, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain<i>Background and Objectives:</i> We aimed to evaluate the oncological and functional outcomes of organ-sparing surgery for testicular germ cell tumors, a procedure that seeks to strike a balance between effective cancer control and organ preservation, in the treatment of testicular tumors. We aimed to discuss the surgical technique and complications, and determine the appropriate candidate selection for this approach. <i>Material and Methods:</i> A comprehensive literature search was conducted to identify relevant studies on organ-sparing surgery for testicular tumors. Various databases, including PubMed, Embase, and Cochrane Library, were used. Studies reporting on surgical techniques, complications, and oncologic and functional outcomes were included for analysis. <i>Results:</i> Current evidence suggests that organ-sparing surgery for testicular germ cell tumors can be considered a safe and efficacious alternative to radical orchiectomy. The procedure is associated with adequate oncological control, as indicated by low recurrence rates and low complication rates. Endocrine testicular function can be preserved in around 80–90% of patients and paternity can be achieved in approximately half of the patients. Candidate selection for this surgery is typically based on the following criteria: pre-surgery normal levels of testosterone and luteinizing hormone, synchronous or metachronous bilateral tumors, tumor in a solitary testis, and tumor size less than 50% of the testis. <i>Conclusions:</i> Organ-sparing surgery for testicular germ cell tumors offers a promising approach that balances oncological control and preservation of testicular function. Further research, including large-scale prospective studies and long-term follow-ups, is warranted to validate the effectiveness and durability of organ-sparing surgery and to identify optimal patient selection criteria.https://www.mdpi.com/1648-9144/59/7/1249testicular cancertesticular tumorsorgan sparingsurgery
spellingShingle Esther García Rojo
Gianluca Giannarini
Borja García Gómez
Javier Amalio Feltes Ochoa
Félix Guerrero Ramos
Manuel Alonso Isa
Ricardo Brime Menendez
David Manuel Saenz Calzada
Juan Justo Quintas
Agustín Fraile
Celeste Manfredi
Javier Romero Otero
Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
Medicina
testicular cancer
testicular tumors
organ sparing
surgery
title Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
title_full Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
title_fullStr Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
title_full_unstemmed Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
title_short Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective
title_sort organ sparing surgery for testicular germ cell tumors a current perspective
topic testicular cancer
testicular tumors
organ sparing
surgery
url https://www.mdpi.com/1648-9144/59/7/1249
work_keys_str_mv AT esthergarciarojo organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT gianlucagiannarini organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT borjagarciagomez organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT javieramaliofeltesochoa organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT felixguerreroramos organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT manuelalonsoisa organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT ricardobrimemenendez organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT davidmanuelsaenzcalzada organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT juanjustoquintas organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT agustinfraile organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT celestemanfredi organsparingsurgeryfortesticulargermcelltumorsacurrentperspective
AT javierromerootero organsparingsurgeryfortesticulargermcelltumorsacurrentperspective